Kristin Hatcher spent three days in Washington, D.C., at the NORD Breakthrough Summit to discuss equitable access to innovation.
Global Liver Institute
GLOBAL LIVER INSTITUTE
Screening for MASLD is Cost-Effective for Patients – Fatty Liver Disease News
In this issue, we explore recent findings that highlight the need for dietary changes, including the link between ultra-processed foods and metabolic disorders in children with obesity, as well as the benefits of increasing plain water intake can reduce mortality risk.
Terri’s Story
When my doctor told me that I had fatty liver disease in 2015, the communication was that it was no big deal. In 2016, I was diagnosed with lupus then pancreatitis. Eventually, the pain, discomfort and fatigue from gallstones led me to an elective gallbladder surgery in 2017. During the surgery, my well-meaning surgeon found my liver to be nodular and decided to biopsy three separate spots while in the process of removing my gallbladder. What my surgeon did not know is how that biopsy would trigger a series of complications for my fragile liver.
Why Hepatitis C Treatment Matters: Improving Patient Outcomes Beyond Liver Health
Hepatitis C continues to be a significant public health concern with effects that reach beyond liver function. As a physician, you’re likely familiar with the chronic health challenges that accompany hepatitis C, especially in patients with multiple comorbidities.
Congress goes into recess in October while staff prepare for a potentially busy November lame-duck session – Liver Health Policy Update
Congress is in recess with Representatives and Senators back in districts and states connecting with their constituents prior to the elections. Their staff are working hard to prepare for what many hope to be a productive November legislative session where some legislative priorities may finally make it to final passage.
Cancer Care for the Underrepresented #Octoberis4Livers – Liver Cancer News
Welcome back to Liver Cancer News! As we mark Liver Cancer Awareness Month in October, we’re emphasizing the critical role of education and awareness in the fight against liver cancer through the #OctoberIs4Livers campaign. Read on for more information about the campaign and for updates on liver cancer care & prevention – especially for populations that face disparities in liver cancer care.
Emerging Evidence in Liver Health: GLP-1, Pollution, and More – Fatty Liver Disease News
Despite awareness efforts, fatty liver disease remains largely overlooked in major global health strategies.
2025 ICD-10 Coding will include code for cholestatic pruritus – Pediatric & Rare Liver Diseases News
Ipsen has achieved progress in the fight against cholestatic diseases, marking two important victories for patients.
As Deadly Liver Cancer Rises, Collaborative, Targeted Prevention and Surveillance Necessary
Global Liver Institute (GLI) launches its seventh annual #OctoberIs4Livers campaign to raise awareness of and address disparities in liver cancer in recognition of Liver Cancer Awareness Month.
Congress reconvenes in September for its last push to legislate before the November elections. – Liver Health Policy Update
Congress is entering a very busy work period in September, the last before the November elections. GLI is preparing for its Advanced Advocacy Academy (A3) and subsequent day on Capitol Hill to advocate for legislation!
Millennials and Generation X Face Higher Risk of Liver Cancer Than Previous Generations – Liver Cancer News
Thank you for being a part of Liver Cancer News! As we gear up for Liver Cancer Awareness Month next month, we are thrilled to announce the launch of a comprehensive patient toolkit designed to support our community throughout their cancer journey.
Let’s Ensure Access to Treatment for PBC Patients – Pediatric & Rare Liver Diseases News
With advancements in second-line treatments for PBC in 2024, both current and new treatment options must remain available, so that every patient can choose the treatment that best meets their needs.